Distribution of interleukin‐1‐immunoreactive microglia in cerebral cortical layers: implications for neuritic plaque formation in Alzheimer’s disease
- 1 August 1998
- journal article
- research article
- Published by Wiley in Neuropathology and Applied Neurobiology
- Vol. 24 (4) , 278-283
- https://doi.org/10.1046/j.1365-2990.1998.00122.x
Abstract
Activated microglia overexpressing interleukin‐1 (IL‐1) are prominent neuropathological features of Alzheimer’s disease. We used computerized image analysis to determine the number of IL‐1α‐immunoreactive (IL‐1α+ ) microglia in cytoarchitectonic layers of parahippocampal gyrus (Brodmann’s area 28) of Alzheimer and control patients. For cortical layers I and II, the numbers of IL‐1α+ microglia were similar in Alzheimer and control patients. For layers III–VI, the numbers of IL‐1α+ microglia were higher than that seen in layers I–II for both Alzheimer and control patients. Moreover, for layers III–VI, the number of IL‐1α+ microglia in Alzheimer patients was significantly greater than that in control patients (relative Alzheimer values of threefold for layer III–V and twofold for layer VI; P+ microglia in Alzheimer patients correlated with the cortical laminar distribution of β‐amyloid precursor protein‐immunoreactive (β‐APP+ ) neuritic plaques found in Alzheimer patients (r=0.99, P+ microglia in control patients also correlated with the cortical laminar distribution of β‐APP+ neuritic plaques found in Alzheimer patients (r=0.91, P+ microglia (i.e. that seen in control patients) are important in determining the observed laminar distribution of β‐APP+ neuritic plaques in Alzheimer patients. These findings provide further support for our hypothesis that IL‐1 is a key driving force in neuritic plaque formation in Alzheimer’s disease.Keywords
This publication has 16 references indexed in Scilit:
- In Vivo and In Vitro Evidence Supporting a Role for the Inflammatory Cytokine Interleukin-1 as a Driving Force in Alzheimer PathogenesisNeurobiology of Aging, 1996
- Microglial inter leukin‐1α expression in brain regions in Alzheimer's disease: correlation with neuritic plaque distributionNeuropathology and Applied Neurobiology, 1995
- Interleukin-1 Expression in Different Plaque Types in Alzheimerʼs DiseaseJournal of Neuropathology and Experimental Neurology, 1995
- S100β protein expression in Alzheimer disease: Potential role in the pathogenesis of neuritic plaquesJournal of Neuroscience Research, 1994
- Differential pattern of β‐amyloid protein deposition within cortical sulci and gyri in Alzheimer's diseaseNeuropathology and Applied Neurobiology, 1993
- Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor.Proceedings of the National Academy of Sciences, 1992
- The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)Neurology, 1991
- Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.Proceedings of the National Academy of Sciences, 1989
- Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells.Proceedings of the National Academy of Sciences, 1989
- Interleukin-1 Stimulation of Astroglial Proliferation After Brain InjuryScience, 1985